Aigen Investment Management, LP Bausch Health Companies Inc. Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$6.1 - $10.41 $96,764 - $165,133	15,863 New	15,863 $110,000
Q3 2022 Nov 09, 2022	SELL	$4.58 - $9.21 $46,097 - $92,698	-10,065 Reduced 47.82%	10,982 $76,000
Q2 2022 Aug 02, 2022	BUY	$7.06 - $23.63 $148,591 - $497,340	21,047 New	21,047 $176,000
Q1 2022 May 05, 2022	SELL	$21.6 - $27.79 $193,536 - $248,998	-8,960 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $206,080 - $259,929	8,960 New	8,960 $226,000
Q1 2020 May 08, 2020	SELL	$12.98 - $30.25 $41,185 - $95,983	-3,173 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$18.89 - $31.89 $59,937 - $101,186	3,173 New	3,173 $95,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.